A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP
AUTHORS
Kazem Anvari 1 , Mehdi Seilanian-Toussi 1 , Hossein Hosseinzad-Ashkiki 2 , Soodabeh Shahidsales 1 , *
How to Cite: Anvari K, Seilanian-Toussi M, Hosseinzad-Ashkiki H, Shahidsales S. A Comparison of 5-HT3 Receptor Antagonist and Metoclopramide in the Patients Receiving Chemotherapeutic Regimens Including CMF, CAF and CHOP, Int J Cancer Manag. 2015 ; 8(2):e80594.
ARTICLE INFORMATION
International Journal of Cancer Management:
8 (2); e80594
Published Online:
April
30,
2015
Article Type:
Research Article
Received:
July
14,
2014
Accepted:
January
07,
2015
READ FULL TEXT
COMMENTS
LEAVE A COMMENT HERE: